<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Virginia Biotechnology Association</title>
	<atom:link href="http://vabio.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://vabio.org</link>
	<description>The voice of the bioscience community in Virginia.</description>
	<lastBuildDate>Fri, 03 Feb 2012 17:05:14 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.3</generator>
	<!-- podcast_generator="podPress/8.8.8" -->
	<copyright>2006-2007 </copyright>
	<managingEditor>scott@pharrout.com (Virginia Biotechnology Association)</managingEditor>
	<webMaster>scott@pharrout.com (Virginia Biotechnology Association)</webMaster>
	<ttl>1440</ttl>
	<image>
		<url>http://www.vabio.org/wp-content/themes/VaBio/images/logo-vabio-300px.gif</url>
		<title>Virginia Biotechnology Association</title>
		<link>http://vabio.org</link>
		<width>144</width>
		<height>144</height>
	</image>
	<itunes:subtitle></itunes:subtitle>
	<itunes:summary>The official podcast of VaBIO, the voice of the bioscience community in Virginia.</itunes:summary>
	<itunes:keywords></itunes:keywords>
	<itunes:category text="Society &amp; Culture" />
	<itunes:author>Virginia Biotechnology Association</itunes:author>
	<itunes:owner>
		<itunes:name>Virginia Biotechnology Association</itunes:name>
		<itunes:email>scott@pharrout.com</itunes:email>
	</itunes:owner>
	<itunes:block>no</itunes:block>
	<itunes:explicit>no</itunes:explicit>
	<itunes:image href="http://www.vabio.org/wp-content/themes/VaBio/images/logo-vabio-300px.gif" />
		<item>
		<title>Companies Expand Export through VEDP Program</title>
		<link>http://vabio.org/companies-expand-export-through-vedp-program/</link>
		<comments>http://vabio.org/companies-expand-export-through-vedp-program/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 14:56:48 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1253</guid>
		<description><![CDATA[Afton Scientific of Albemarle County, and Mediatech of Prince William County were among the six companies from across the Commonwealth to graduate from Virginia Economic Development Partnership’s (VEDP) Virginia Leaders in Export Trade (VALET) program.  The six companies collectively have ...]]></description>
			<content:encoded><![CDATA[Afton Scientific of Albemarle County, and Mediatech of Prince William County were among the six companies from across the Commonwealth to graduate from Virginia Economic Development Partnership’s (VEDP) Virginia Leaders in Export Trade (VALET) program.  The six companies collectively have ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/companies-expand-export-through-vedp-program/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>2012 General Assembly Opens in Richmond</title>
		<link>http://vabio.org/2012-general-assembly-opens-in-richmond/</link>
		<comments>http://vabio.org/2012-general-assembly-opens-in-richmond/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 14:07:55 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1250</guid>
		<description><![CDATA[The 140 members of the Virginia House of Delegates and State Senate are back in Richmond for the 2012 legislative session, facing tough decisions on the state budget, transportation, higher education, K-12 education, state pensions and economic development initiatives. The Virginia Biotechnology ...]]></description>
			<content:encoded><![CDATA[The 140 members of the Virginia House of Delegates and State Senate are back in Richmond for the 2012 legislative session, facing tough decisions on the state budget, transportation, higher education, K-12 education, state pensions and economic development initiatives.
The Virginia Biotechnology ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/2012-general-assembly-opens-in-richmond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;U.Va. Innovation&#8217; to Foster new Ventures</title>
		<link>http://vabio.org/u-va-innovation-to-foster-new-ventures/</link>
		<comments>http://vabio.org/u-va-innovation-to-foster-new-ventures/#comments</comments>
		<pubDate>Tue, 24 Jan 2012 22:07:05 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1248</guid>
		<description><![CDATA[U.Va. Innovation is a new University-wide initiative led by W. Mark Crowell, executive director of U.Va. Innovation and associate vice president for research, designed to enhance the activities of the University&#8217;s researchers and entrepreneurs and maximize the impact of innovative U.Va. ...]]></description>
			<content:encoded><![CDATA[U.Va. Innovation is a new University-wide initiative led by W. Mark Crowell, executive director of U.Va. Innovation and associate vice president for research, designed to enhance the activities of the University&#8217;s researchers and entrepreneurs and maximize the impact of innovative U.Va. ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/u-va-innovation-to-foster-new-ventures/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oxford Provides $15M Senior Credit Facility</title>
		<link>http://vabio.org/oxford-provides-15m-senior-credit-facility/</link>
		<comments>http://vabio.org/oxford-provides-15m-senior-credit-facility/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 20:33:05 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1242</guid>
		<description><![CDATA[Oxford Finance LLC., a specialty finance firm that provides senior debt to life sciences and healthcare services companies based in Alexandria, announced a $15 million round of debt financing for Vitae Pharmaceuticals, a clinical‐stage biopharmaceutical company discovering and developing a ...]]></description>
			<content:encoded><![CDATA[Oxford Finance LLC., a specialty finance firm that provides senior debt to life sciences and healthcare services companies based in Alexandria, announced a $15 million round of debt financing for Vitae Pharmaceuticals, a clinical‐stage biopharmaceutical company discovering and developing a ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/oxford-provides-15m-senior-credit-facility/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CIT GAP Funds Invests in SphynKx Therapeutics</title>
		<link>http://vabio.org/cit-gap-funds-invests-in-sphynkx-therapeutics/</link>
		<comments>http://vabio.org/cit-gap-funds-invests-in-sphynkx-therapeutics/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 20:08:06 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1241</guid>
		<description><![CDATA[The Center for Innovative Technology (CIT) has made a $50,000 investment in Charlottesville, Va.-based SphynKx Therapeutics LLC. SphynKx focuses on the discovery and development of small molecule therapeutics that target the sphingosine 1-phosphate (S1P) pathway in novel ways, potentially leading to ...]]></description>
			<content:encoded><![CDATA[The Center for Innovative Technology (CIT) has made a $50,000 investment in Charlottesville, Va.-based SphynKx Therapeutics LLC. SphynKx focuses on the discovery and development of small molecule therapeutics that target the sphingosine 1-phosphate (S1P) pathway in novel ways, potentially leading to ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/cit-gap-funds-invests-in-sphynkx-therapeutics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>VA Healthcare Innovators Call for Nominations</title>
		<link>http://vabio.org/va-healthcare-innovators-call-for-nominations/</link>
		<comments>http://vabio.org/va-healthcare-innovators-call-for-nominations/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 21:32:50 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1240</guid>
		<description><![CDATA[In today’s rapidly evolving healthcare environment, improving the quality and efficiency of healthcare delivery is more important than ever. The healthcare industry must therefore foster and encourage progress and creativity. The 2012 Virginia Healthcare Innovators Awards honors Virginia providers ...]]></description>
			<content:encoded><![CDATA[In today’s rapidly evolving healthcare environment, improving the quality and efficiency of healthcare delivery is more important than ever. The healthcare industry must therefore foster and encourage progress and creativity. The 2012 Virginia Healthcare Innovators Awards honors Virginia providers ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/va-healthcare-innovators-call-for-nominations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Best Practices in Technology Transfer</title>
		<link>http://vabio.org/video-best-practices-in-technology-transfer/</link>
		<comments>http://vabio.org/video-best-practices-in-technology-transfer/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 14:43:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1237</guid>
		<description><![CDATA[Click here for the video of the January 12 VABIO Greater Richmond Bioscience Luncheon. The program,“Commercializing Translational Research: Best Practices in Technology Transfer,” was recorded before a sold out crowd of nearly 90 bioscience leaders in the Greater Richmond community. What are the ...]]></description>
			<content:encoded><![CDATA[Click here for the video of the January 12 VABIO Greater Richmond Bioscience Luncheon. The program,“Commercializing Translational Research: Best Practices in Technology Transfer,” was recorded before a sold out crowd of nearly 90 bioscience leaders in the Greater Richmond community.
What are the ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/video-best-practices-in-technology-transfer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CIT Invests $50K in Rivanna Medical</title>
		<link>http://vabio.org/cit-invests-50k-in-rivanna-medical/</link>
		<comments>http://vabio.org/cit-invests-50k-in-rivanna-medical/#comments</comments>
		<pubDate>Mon, 09 Jan 2012 18:51:00 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1235</guid>
		<description><![CDATA[The Center for Innovative Technology (CIT) has announced a $50,000 investment in University of Virginia based start-up Rivanna Medical, a company specializing in portable, low-cost, radiation-free X-ray replacement technology based on medical ultrasound. Rivanna Medical’s proprietary ultrasound ...]]></description>
			<content:encoded><![CDATA[The Center for Innovative Technology (CIT) has announced a $50,000 investment in University of Virginia based start-up Rivanna Medical, a company specializing in portable, low-cost, radiation-free X-ray replacement technology based on medical ultrasound.
Rivanna Medical’s proprietary ultrasound ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/cit-invests-50k-in-rivanna-medical/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novozymes Donates $50K to Radford for Lab</title>
		<link>http://vabio.org/novoyzmes-donates-50k-to-radford-for-lab/</link>
		<comments>http://vabio.org/novoyzmes-donates-50k-to-radford-for-lab/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 22:03:29 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1231</guid>
		<description><![CDATA[Novozymes Biologicals has made a $50,000 gift to Radford University for a laboratory in the new Center for the Sciences building.  The Novozymes Biology Lab will be a teaching laboratory for introductory biology courses for undergraduate students. “We are grateful to Novozymes Biologicals for ...]]></description>
			<content:encoded><![CDATA[Novozymes Biologicals has made a $50,000 gift to Radford University for a laboratory in the new Center for the Sciences building.  The Novozymes Biology Lab will be a teaching laboratory for introductory biology courses for undergraduate students.
“We are grateful to Novozymes Biologicals for ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/novoyzmes-donates-50k-to-radford-for-lab/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jeremy Levin to Become CEO of Teva</title>
		<link>http://vabio.org/jeremy-levin-to-become-ceo-of-teva/</link>
		<comments>http://vabio.org/jeremy-levin-to-become-ceo-of-teva/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 21:16:17 +0000</pubDate>
		<dc:creator>shalloran</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://vabio.org/?p=1230</guid>
		<description><![CDATA[Teva Pharmaceutical Industries Ltd., has announced that Shlomo Yanai, President and CEO of Teva, plans to retire from the company effective May 2012, and that as part of a succession plan, the Board of Directors has named Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb to succeed ...]]></description>
			<content:encoded><![CDATA[Teva Pharmaceutical Industries Ltd., has announced that Shlomo Yanai, President and CEO of Teva, plans to retire from the company effective May 2012, and that as part of a succession plan, the Board of Directors has named Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb to succeed ...]]></content:encoded>
			<wfw:commentRss>http://vabio.org/jeremy-levin-to-become-ceo-of-teva/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

